Guardant Health, Inc.
Guardant Health, Inc. (GH) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
gh · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Guardant Health, Inc. (GH) measures how much investors pay for each dollar of the company's trailing earnings. GH's current PE ratio of N/A is calculated by dividing its stock price of $127.59 by its TTM earnings per share of -$3.30.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2016 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Guardant Health, Inc.You GH | $16.9B | N/A | — | -$3.30 |
 Ascendis Pharma A/S ASND | $12.6B | N/A | — | -$3.61 |
 BridgeBio Pharma, Inc. BBIO | $13.2B | N/A | — | -$3.70 |
 Encompass Health Corporation EHC | $10.1B | 18.84x | -53.6% | $5.63 |
 Exact Sciences Corporation EXAS | $20.0B | N/A | — | -$1.10 |
 ICON Public Limited Company ICLR | $11.6B | 62.31x | +53.6% | $2.92 |
 Ionis Pharmaceuticals, Inc. IONS | $12.1B | N/A | — | -$2.38 |
Industry Average 2 peers with valid PE | — | 40.58x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-3.32 | — | |
2024-12-31 FY2024 | — | $-3.56 | — | |
2023-12-31 FY2023 | — | $-4.28 | — | |
2022-12-31 FY2022 | — | $-6.41 | — | |
2021-12-31 FY2021 | — | $-4.00 | — | |
2020-12-31 FY2020 | — | $-2.60 | — | |
2019-12-31 FY2019 | — | $-0.84 | — | |
2018-12-31 FY2018 | — | $-1.00 | — | |
2017-12-31 FY2017 | — | $-1.18 | — | |
2016-12-31 FY2016 | — | $-3.49 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Guardant Health, Inc. (GH) measures how much investors pay for each dollar of the company's trailing earnings. GH's current PE ratio of N/A is calculated by dividing its stock price of $127.59 by its TTM earnings per share of -$3.30.
Frequently asked questions
GH pe ratio · 6 questionsGH's current PE ratio is N/A as of 2026-06-08, based on a stock price of $127.59 and TTM EPS of -$3.30. Data sourced from Financial Modeling Prep via GH's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Guardant Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08